0001708138-20-000054.txt : 20200511 0001708138-20-000054.hdr.sgml : 20200511 20200511163921 ACCESSION NUMBER: 0001708138-20-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200508 FILED AS OF DATE: 20200511 DATE AS OF CHANGE: 20200511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20865504 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-05-08 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research and Development Common Stock 2020-05-08 4 M 0 12500 52.03 A 23880 D Common Stock 2020-05-08 4 F 0 7195 560.67 D 16685 D Common Stock 2020-05-11 4 S 0 312 567.5 D 16373 D Common Stock 2020-05-11 4 S 0 792 568.71 D 15581 D Common Stock 2020-05-11 4 S 0 2175 569.39 D 13406 D Common Stock 2020-05-11 4 S 0 2026 570.28 D 11380 D Common Stock 5763 I By 401(k) Plan Common Stock 7831 I by 2018 GRAT Common Stock 13700 I by 2019 GRAT Non-Qualified Stock Option (right to buy) 52.03 2020-05-08 4 M 0 12500 0.0 D 2021-12-16 Common Stock 12500 12500 D Represents volume-weighted average price of sales of 312 shares of Company stock on May 11, 2020 at prices ranging from $567.11 to $567.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price. Represents volume-weighted average price of sales of 792 shares of Company stock on May 11, 2020 at prices ranging from $568.00 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price. Represents volume-weighted average price of sales of 2,175 shares of Company stock on May 11, 2020 at prices ranging from $569.00 to $569.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price. Represents volume-weighted average price of sales of 2,026 shares of Company stock on May 11, 2020 at prices ranging from $570.00 to $570.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 11, 2020 at each separate price. With respect to 75,000 underlying shares (of which 12,500 remain outstanding) the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. /s/**Neil Stahl 2020-05-11